Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_18-cv-00355/USCOURTS-cand-3_18-cv-00355-1/pdf.json

Nature of Suit Code: 890
Nature of Suit: Other Statutory Actions
Cause of Action: 15:1125 Trademark Infringement (Lanham Act)

---

1 

STIPULATION AND [PROPOSED] REVISED SCHEDULING ORDER CONCERNING DEFENDANT’S 

 REPLY IN SUPPORT OF ITS PENDING MOTION TO DISMISS AND HEARING REGARDING THE SAME 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

WILLIAM SENIOR, ESQ. (CSB: 263373) 

BENJAMIN L. ENGLAND & ASSOCIATES, LLC 

3711 Long Beach Blvd., Suite 714 

Long Beach, CA 90807 

Tel: (562) 285-3400 

Fax: (443) 583-1464 

wjsenior@fdaimports.com 

Attorney for Defendant 

ECI PHARMACEUTICALS LLC 

ROCKY TSAI (CSB # 221452) 

ROPES & GRAY LLP 

Three Embarcadero Center 

San Francisco, CA 94111-4006 

Tel: 415-315-6300 

Fax: 415-315-6350 

rocky.tsai@ropesgray.com 

PETER M. BRODY (pro hac vice) 

MICHAEL J. GERSHONI (CSB # 311192) 

2099 Pennsylvania Avenue, NW 

Washington, DC 20006-6807 

Tel: 202-508-4600 

Fax: 202-508-4650 

peter.brody@ropesgray.com 

michael.gershoni@ropesgray.com 

EVAN GOURVITZ (pro hac vice) 

1211 Avenue of the Americas 

New York, NY 10036-8704 

Tel: 212-596-9000 

Fax: 212-596-9090 

evan.gourvitz@ropesgray.com 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

SAN FRANCISCO DIVISION 

VALEANT PHARMACEUTICALS NORTH 

AMERICA, LLC, 

Plaintiff, 

v. 

ECI PHARMACEUTICALS LLC 

Defendant. 

Case No. 18-CV-00355-RS 

STIPULATION AND [PROPOSED] 

REVISED SCHEDULING ORDER 

CONCERNING DEFENDANT’S REPLY 

IN SUPPORT OF ITS PENDING MOTION 

TO DISMISS AND HEARING 

REGARDING THE SAME

Case 3:18-cv-00355-RS Document 79 Filed 09/27/18 Page 1 of 5
 2 

STIPULATION AND [PROPOSED] REVISED SCHEDULING ORDER CONCERNING DEFENDANT’S 

 REPLY IN SUPPORT OF ITS PENDING MOTION TO DISMISS AND HEARING REGARDING THE SAME 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

Pursuant to Civil Local Rule 7-2, 7-3, 7-7, and 7-12, Parties to the above-entitled action, 

by and through their undersigned counsel, hereby stipulate to the following: 

1. An order granting a Stay in the above-titled action was issued on May 4, 2018 

pursuant to 28 U.S.C. 1659(a). This order suspended all filing deadlines relevant to this matter, 

and has not yet been superseded. 

2. As such, Parties to this action hereby stipulate to the proposed schedule for casespecific deadlines for Valeant Pharmaceuticals NA, LLC v. ECI Pharmaceuticals LLC, 3:18-cv00355-RS: 

Event Date 

Deadline for Defendant’s Reply in Support of its 

Motion to Dismiss 

October 12, 2018 

Joint Hearing on Defendant’s Motion to Dismiss October 25, 2018 1:30pm PST 

Courtroom 03, 17th Floor 

3. Consequently, the Parties to this action formally request a Joint Hearing on 

Defendant’s Motion to Dismiss at the same time as the hearing for the Virtus Defendants has 

been ordered in Valeant Pharmaceuticals North America LLC v. Virtus Pharmaceuticals, LLC & 

Virtus Pharmaceuticals OPCO II, LLC, Case No. 3:17-cv-06731-RS at D.E. 77. Namely, that 

the Joint Hearing take place on October 25, 2018 at 1:30 p.m., Courtroom 3, 17th Floor. 

4. The Defendant’s motions to dismiss present certain common issues of fact and 

law. The Parties to this action therefore believe that conducting this hearing in conjunction with 

the hearing on Virtus Defendants’ motions will promote efficiency and judicial economy. 

Dated: September 24, 2018 

Case 3:18-cv-00355-RS Document 79 Filed 09/27/18 Page 2 of 5
 3 

STIPULATION AND [PROPOSED] REVISED SCHEDULING ORDER CONCERNING DEFENDANT’S 

 REPLY IN SUPPORT OF ITS PENDING MOTION TO DISMISS AND HEARING REGARDING THE SAME 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

ROPES & GRAY LLP 

By:_/s/ Rocky Tsai, Esq._____________ 

 Rocky Tsai, Esq. (CSB No. 221452) 

Attorney for Plaintiff, Valeant 

Pharmaceuticals North America LLC 

Three Embarcadero Center 

San Francisco, California 94111 

Tel: (415) 315-6300 

Fax: (415) 315-6350 

rocky.tsai@ropesgray.com

BENJAMIN L. ENGLAND & ASSOCIATES, 

LLC 

By:_/s/ William J. Senior, Esq.__________ 

 William J. Senior, Esq. (CBN: 263373) 

Attorney for Defendant, 

ECI Pharmaceuticals LLC 

3711 Long Beach Blvd., Suite 714 

Long Beach, CA 90807 

Tel: (562) 285-3400 

Fax: (443) 583-1464 

wjsenior@fdaimports.com

 

Case 3:18-cv-00355-RS Document 79 Filed 09/27/18 Page 3 of 5
 4 

STIPULATION AND [PROPOSED] REVISED SCHEDULING ORDER CONCERNING DEFENDANT’S 

 REPLY IN SUPPORT OF ITS PENDING MOTION TO DISMISS AND HEARING REGARDING THE SAME 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

[PROPOSED] ORDER 

PURSUANT TO STIPULATION, IT IS SO ORDERED. 

Dated: ________________, 2018 _______________________________________ 

United States District Judge 

September 27

Case 3:18-cv-00355-RS Document 79 Filed 09/27/18 Page 4 of 5
 5 

STIPULATION AND [PROPOSED] REVISED SCHEDULING ORDER CONCERNING DEFENDANT’S 

 REPLY IN SUPPORT OF ITS PENDING MOTION TO DISMISS AND HEARING REGARDING THE SAME 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

CERTIFICATE OF SERVICE 

The undersigned counsel for Defendant ECI Pharmaceuticals LLC, hereby certifies that 

on September 24, 2018, a true and correct copy of the foregoing STIPULATION AND 

[PROPOSED] REVISED SCHEDULING ORDER CONCERNING DEFENDANT’S 

REPLY IN SUPPORT OF ITS PENDING MOTION TO DISMISS AND HEARING 

REGARDING THE SAME was filed with the Court and served electronically by the Court’s 

CM/ECF System to all registered users. 

 /s/ William J. Senior, Esq. 

Attorney for Defendant ECI Pharmaceuticals LLC 

CIVIL LOCAL RULE 5-1(i)(3) ATTESTATION 

I hereby attest that concurrence in the filing of the document has been obtained from 

each of the other Signatories, which shall serve in lieu of their signatures to this document. 

 /s/ Carlton LP Talbot, Esq. 

 By: Carlton Talbot, Esq. 

Case 3:18-cv-00355-RS Document 79 Filed 09/27/18 Page 5 of 5